What Alvalin 40mg/g is used for?
Alvalin 40mg/g is indicated for the supportive treatment of obese patients with a body mass index (BMI) of at least 30, provided that the affected person did not respond to suitable weight-reducing measures alone.
Which persons should not take Alvalin 40mg?
Children under the age of 12, pregnant women and nursing mothers should not be prescribed the weight-reducing medication. Breastfeeding patients are advised to give up immediately if they do. Adolescents under the age of 18 may consume the appetite-reducing agent only in consultation with their attending physician. Through our customer service, you can only request treatment with Alvalin from the age of 18.
Contraindications
- Alvalin should not be used for subsequent diseases:
- severe hypertension
- Pulmonary hypertension
- known cardiovascular diseases
- Disorders of cerebral circulation
- Angina pectoris
- anorexia
- depressions
- addictions
- Tumors of the adrenals
- Thyroid secondary function
- Other diseases
For some diseases, the doctor must carefully weigh the risks and benefits of taking them.
This applies to all heart diseases, enlargement of the prostate gland with residual urine formation, metabolic diseases such as diabetes and epilepsy. Targeted weight reduction can be beneficial for the patient.
Dosage of Alvalin 40mg oral drops
According to the general dose recommendation, adolescents 12 years and older should take 4 to 8 drops of alvaline twice daily, approximately 30 minutes before the meal, in the morning and at noon. Alternatively, 8 to 12 drops can be taken once daily in the morning after the first meal. The intake is undiluted. Then drink plenty of fluid.
How it works
The active substance contained in Alvalin releases a transmitter substance. This stimulates the involuntary nervous system to achieve an inhibition of the appetite in the brain. This should provide for a reduced food intake, which in turn should lead by a lower calorie intake to a weight loss. Conact our online support.
Reviews
There are no reviews yet.